Patents by Inventor Manuel Campo

Manuel Campo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230283378
    Abstract: The present invention relates to a dual GPON Small Form-Factor Pluggable optical module, projected to provide connection to two SC optical fiber connectors, and to be incorporated in any state of the art SFP transceiver host to allow double GPON-OLT channels. The module comprises a case housing a specific set of technical elements such as bidirectional optical subassemblies, high-speed electrical interface, and all the necessary electronic circuits, printed circuit board and flex-printed circuit board to ensure proper assembly and electronic performance of all elements.
    Type: Application
    Filed: April 12, 2021
    Publication date: September 7, 2023
    Inventors: Cláudio Emanuel GOMES FERREIRINHO LIMA RODRIGUES, Paulo Jorge DA COSTA MÃO CHEIA, Joaquim Fernando VALE E SERRA, Tiago Manuel CAMPOS, Luis Miguel AMARAL HENRIQUES
  • Patent number: 10261092
    Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: April 16, 2019
    Assignee: Elanco Tiergesundheit AG
    Inventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Keil
  • Publication number: 20150293118
    Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.
    Type: Application
    Filed: April 27, 2015
    Publication date: October 15, 2015
    Applicant: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Keil
  • Patent number: 9096554
    Abstract: The present invention relates to compounds with a benzoxadiazolyl amine structure which are capable of inhibiting the activation or the biological activity of p38 mitogen-activated protein kinase (MAPK) and the use thereof in the treatment of a disease that can be alleviated by means of inhibiting the activation or the biological activity of said p38 MAPK, for example, an inflammatory disease or a disease presenting with pain.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: August 4, 2015
    Assignee: UNIVERSIDAD AUTÓNOMA DE MADRID
    Inventors: Federico Mayor Menéndez, Cristina Murga Montesinos, Pedro Manuel Campos Muelas, Jacoba Johana Heijnen, Anna Maria Agnes Antonius Kavelaars, Antonio Morreale de León, Rubén Gil Redondo
  • Patent number: 9046528
    Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: June 2, 2015
    Assignee: Novartis Tiergesundheit AG
    Inventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Keil
  • Publication number: 20140296308
    Abstract: The present invention relates to compounds with a benzoxadiazolyl amine structure which are capable of inhibiting the activation or the biological activity of p38 mitogen-activated protein kinase (MAPK) and the use thereof in the treatment of a disease that can be alleviated by means of inhibiting the activation or the biological activity of said p38 MAPK, for example, an inflammatory disease or a disease presenting with pain.
    Type: Application
    Filed: October 31, 2012
    Publication date: October 2, 2014
    Inventors: Federico Mayor Ménendez, Cristina Murga Montesinos, Pedro Manuel Campos Muelas, Jacoba Johana Heijnen, Anna Maria Agnes Antonius Kavelaars, Antonio Morreale de León, Rubén Gil Redondo
  • Publication number: 20120276282
    Abstract: A process of coating at least one substrate with a plurality of deposition sources, a method of tooling, a carrier unit and a deposition system are described. The systems and methods provide for or allow for exposing a first substrate portion 112a of said at least one substrate 112 to a first deposition source 118a through an aperture 122 of a carrier unit 110, 510, depositing a first layer 126a over the first substrate portion, said first layer including material from said first deposition source, varying a relative position between said at least one substrate and said aperture for exposing a second substrate portion of said at least one substrate, or another substrate, to a second deposition source, and depositing a second layer 126b over the second substrate portion 112b, said second layer including material from said second deposition source.
    Type: Application
    Filed: May 10, 2011
    Publication date: November 1, 2012
    Applicant: APPLIED MATERIALS, INC.
    Inventors: Uwe HOFFMANN, Manuel CAMPO
  • Publication number: 20110014225
    Abstract: Compositions and methods for determining immunologically cross-reactive molecules comprising a cross-reactive antigenic determinant are provided, in particular for determining proteins comprising cross-reactive antigenic determinants, in particular for determining proteins that are cross-reactive based on serological screens using sequential immunological challenges to an animal, including determining cross-reactive H. parasuis proteins. Also provided are compositions, vaccines, and kits using the molecules for diagnostics and methods for preventing or treating a disease, disorder, condition, or symptoms thereof associated with infectious agents, in particular infectious microorganisms, in particular for preventing or treating a disease, disorder, condition, or symptom thereof associated with H. parasuis infection.
    Type: Application
    Filed: March 20, 2009
    Publication date: January 20, 2011
    Applicant: NOVARTIS AG
    Inventors: Thomas Plocher, Manuel Campos, Richard Harland, Todd Johnson, Trent Harbison, Dan Kiel
  • Publication number: 20100194287
    Abstract: An electronic ballast for an HID lamp is described, comprising: a rectifier circuit; a PFC power factor correction circuit increasing the direct current (DC) voltage coming out from the rectifier circuit; a current converter receiving the high voltage DC and converts it to alternating current (AC) to be supplied to the lamp; an ignition circuit generating ignition pulses being fed to the converter circuit to turn on the lamp, the pulses are generated by a downward frequencies scan, and, a control circuit commanding the operation of the ignition circuit and controlling the power being supplied to the lamp according to a power profile being determined by the lightning conditions desired to be obtained from said lamp to save energy. The operative method for the ballast is also described.
    Type: Application
    Filed: January 29, 2008
    Publication date: August 5, 2010
    Inventors: Roberto Vivero-Flores, Alberto Manuel Campos-Violante
  • Publication number: 20080233097
    Abstract: A new phosphorylation site of mitogen-activated kinase proteins (MAPK) has been found. Phosphorylated MAPKs in said phosphorylation site can be used as a diagnostic marker of pathologies mediated by MAPKs.
    Type: Application
    Filed: June 9, 2006
    Publication date: September 25, 2008
    Applicant: UNIVERSIDAD AUTONOMA DE MADRID
    Inventors: Cristina Murga Montesinos, Federico Mayor Menendez, Maria Jurado Pueyo, Pedro Manuel Campo Muelas, Sandra Peregrin Pedrique
  • Patent number: 6911206
    Abstract: The subject invention provides a fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises: (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate; connected to (b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate; the portion (b) causing the vertebrate's immune system to recognize the portion (a) and produce a response that: (i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and (ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein.
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: June 28, 2005
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Manuel Campos, Terecita D. Yule, Serge Martinod, Becky A. Durtschi
  • Publication number: 20050095258
    Abstract: The subject invention provides a fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises: (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate; connected to (b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate; the portion (b) causing the vertebrate's immune system to recognize the portion (a) and produce a response that: (i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and (ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein.
    Type: Application
    Filed: November 29, 2004
    Publication date: May 5, 2005
    Inventors: Manuel Campos, Terecita Yule, Serge Martinod, Becky Durtschi
  • Publication number: 20040223982
    Abstract: The present invention provides an homogenate prepared from cells of Neospora, and vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.
    Type: Application
    Filed: June 21, 2004
    Publication date: November 11, 2004
    Inventors: David A. Brake, Manuel Campos
  • Publication number: 20040198954
    Abstract: The present invention is directed to five novel, low molecular weight proteins from Actinobacillus pleuropneumoniae (APP), which are capable of inducing, or contributing to the induction of, a protective immune response in swine against APP. The present invention is further directed to polynucleotide molecules having nucleotide sequences that encode the proteins, as well as vaccines comprising the proteins or polynucleotide molecules, and methods of making and using the same.
    Type: Application
    Filed: February 3, 2004
    Publication date: October 7, 2004
    Inventors: Robert G. Ankenbauer, Mary Jo Baarsch, Manuel Campos, Robin Keich, Everett Rosey, Brian Suiter, Lynn Warren-Stewart
  • Patent number: 6787146
    Abstract: The present invention provides an homogenate prepared from cells of Neospora, and vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: September 7, 2004
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: David A. Brake, Manuel Campos
  • Patent number: 6713071
    Abstract: The present invention is directed to five novel, low molecular weight proteins from Actinobacillus pleuropneumoniae (APP), which are capable of inducing, or contributing to the induction of, a protective immune response in swine against APP. The present invention is further directed to polynucleotide molecules having nucleotide sequences that encode the proteins, as well as vaccines comprising the proteins or polynucleotide molecules, and methods of making and using the same.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: March 30, 2004
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Robert G. Ankenbauer, Mary Jo Baarsch, Manuel Campos, Robin Keich, Everett Rosey, Brian Suiter, Lynn Warren-Stewart
  • Publication number: 20020058046
    Abstract: The present invention provides an homogenate prepared from cells of Neospora, and vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.
    Type: Application
    Filed: November 9, 2001
    Publication date: May 16, 2002
    Applicant: Pfizer Inc.
    Inventors: David A. Brake, Manuel Campos
  • Patent number: 6270800
    Abstract: A microencapsulated subunit component from bovine herpes virus-1 (BHV-1) is disclosed. Vaccines, kits, and methods for using the same to vaccinate a member of a bovine species are also disclosed.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: August 7, 2001
    Assignee: Pfizer Inc.
    Inventors: Tully J. Speaker, H. Fred Clark, Charlotte A. Moser, Paul A. Offit, Manuel Campos, Patrick J. Frenchick
  • Patent number: 6096320
    Abstract: New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of an RTX cytotoxin fused to an active fragment of a cytokine. The chimeric proteins can be used in a vaccine composition. Also disclosed are methods of vaccination as well as methods of making the proteins employed in the vaccines.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: August 1, 2000
    Assignees: University of Saskatchewan, Ciba-Geigy Canada Ltd.
    Inventors: Andrew Potter, Manuel Campos, Huw P. A. Hughes
  • Patent number: 5594107
    Abstract: New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of an RTX cytotoxin fused to an active fragment of a cytokine. The chimeric proteins can be used in a vaccine composition. Also disclosed are methods of vaccination as well as methods of making the proteins employed in the vaccines.
    Type: Grant
    Filed: December 20, 1993
    Date of Patent: January 14, 1997
    Assignees: University of Saskatchewan, Ciba-Geigy Canada Ltd.
    Inventors: Andrew Potter, Manuel Campos, Huw P. A. Hughes